Vol 212, Issue 7: 20 April, 2020. Associate Professor Peter (Shane) Hamblin is a consultant endocrinologist and Director of Diabetes and Endocrinology at Western Health in Victoria. He discusses SGLT2 inhibitors and the rare, but important risk of diabetic ketoacidosis. With MJA news and online editor, Cate Swannell. 22 mins, 19 secs.